Displaying 821 - 840 of 853
| Active Ingredient | MULTIVITAMINS PAEDIATRIC WITH IRON |
| Therapeutic Class | MULTIVITAMIN PREPARATIONS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MULTIVITAMINS PRENATAL |
| Therapeutic Class | MULTIVITAMIN PREPARATIONS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ALCOHOL |
| Therapeutic Class | UNCLASSIFIED THERAPEUTIC AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ETANERCEPT |
| Therapeutic Class | UNCLASSIFIED THERAPEUTIC AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | NABILONE |
| Therapeutic Class | UNCLASSIFIED THERAPEUTIC AGENTS |
| Indications | Used for the control of nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic. Even though it is structurally distinct fr More ... |
| Caution | The adverse effects are similar to those of cannabis. The most common are drowsiness, vertigo, and dry mouth. Neurological effects have included ataxia, confusion, disorientation, dizziness,euphoria, More ... |
| Dose Range | A dose of 1 mg - 2 mg twice daily, orally every 8-12hours. The first dose is given the evening before, or 1-3 hours before chemotherapy. Nabilone is given throughout the chemotherapy and for 24-48 hours after the last dose of chemotherapy. Not to exceed 6 |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PHENOXYTOL |
| Therapeutic Class | UNCLASSIFIED THERAPEUTIC AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | SULBUTIAMINE |
| Therapeutic Class | UNCLASSIFIED THERAPEUTIC AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DUTASTERIDE |
| Therapeutic Class | 5 ALPHA REDUCTASE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DUTASTERIDE | TAMSULOSIN |
| Therapeutic Class | 5 ALPHA REDUCTASE INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FINASTERIDE |
| Therapeutic Class | 5 ALPHA REDUCTASE INHIBITORS |
| Indications | Benign prostatic hyperplasia. |
| Caution |
Women/children should not handle tablets. Neoplasm of breast, breast tenderness and swelling, ejaculation disorders erectile dy sfunction, rash, urticaria, depression, testicular pain and decreased More ... |
| Dose Range | 5mg once daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ACETYLCYSTEINE |
| Therapeutic Class | ANTIDOTES |
| Indications |
Treatment of paracetamol overdose, if patient is seen within 20 hours after overdose of 20-30 tablets. |
| Caution | |
| Dose Range |
150mg/kg IV in 200ml of 5% dextrose over 15 minutes then 50mg/kg in 50ml 5% dextrose over 4 hours, then 100mg/kg IV in 1L 5% dextrose over 16 hours. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CALCIUM FOLINATE |
| Therapeutic Class | ANTIDOTES |
| Indications | Antidote to folic acid antagonists, such as methotrexate. adjunct to fluorouracil in the treatment of colorectal cancer. |
| Caution | Occasional hypersensitivity, including anaphylactic reactions. |
| Dose Range |
Dosage and duration adapted according to the methotrexate regimen and the patient's ability to clear the antineoplastic. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | LEUCOVORIN |
| Therapeutic Class | ANTIDOTES |
| Indications | Antidote to folic acid antagonists, such as methotrexate. adjunct to fluorouracil in the treatment of colorectal cancer. |
| Caution | Occasional hypersensitivity, including anaphylactic reactions. |
| Dose Range | Dosage and duration adapted according to the methotrexate regimen and the patient's ability to clear the antineoplastic. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | THALIDOMIDE |
| Therapeutic Class | BIOLOGIC RESPONSE MODIFIER |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ALENDRONATE |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | Treatment and p revention of osteop orosis. |
| Caution |
Abdominal pain, dyspepsia, diarrhoea or constipation. Patients should be instructed to avoid lying down for at least 30 minutes following administration of alendronate to minimize potential esophageal More ... |
| Dose Range | 70mg once weekly with a full glass of water on morning on an empty stomach, at least 30 minutes before breakfast and any other oral medication. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | IBANDRONIC ACID |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RISEDRONATE |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | RISENDRONATE |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ZOLENDRONIC ACID |
| Therapeutic Class | BONE RESORPTION INHIBITORS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | LEFLUNOMIDE |
| Therapeutic Class | DISEASE MODIFYING ANTIRHEUMATIC AGENTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |